These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

643 related articles for article (PubMed ID: 25416383)

  • 1. The role of inflammation in hypoxic pulmonary hypertension: from cellular mechanisms to clinical phenotypes.
    Pugliese SC; Poth JM; Fini MA; Olschewski A; El Kasmi KC; Stenmark KR
    Am J Physiol Lung Cell Mol Physiol; 2015 Feb; 308(3):L229-52. PubMed ID: 25416383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergence of fibroblasts with a proinflammatory epigenetically altered phenotype in severe hypoxic pulmonary hypertension.
    Li M; Riddle SR; Frid MG; El Kasmi KC; McKinsey TA; Sokol RJ; Strassheim D; Meyrick B; Yeager ME; Flockton AR; McKeon BA; Lemon DD; Horn TR; Anwar A; Barajas C; Stenmark KR
    J Immunol; 2011 Sep; 187(5):2711-22. PubMed ID: 21813768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Time- and Compartment-Specific Activation of Lung Macrophages in Hypoxic Pulmonary Hypertension.
    Pugliese SC; Kumar S; Janssen WJ; Graham BB; Frid MG; Riddle SR; El Kasmi KC; Stenmark KR
    J Immunol; 2017 Jun; 198(12):4802-4812. PubMed ID: 28500078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single cell transcriptomic analyses reveal diverse and dynamic changes of distinct populations of lung interstitial macrophages in hypoxia-induced pulmonary hypertension.
    Kumar S; Mickael C; Kumar R; Prasad RR; Campbell NV; Zhang H; Li M; McKeon BA; Allen TE; Graham BB; Yu YA; Stenmark KR
    Front Immunol; 2024; 15():1372959. PubMed ID: 38690277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic reprogramming and inflammation act in concert to control vascular remodeling in hypoxic pulmonary hypertension.
    Stenmark KR; Tuder RM; El Kasmi KC
    J Appl Physiol (1985); 2015 Nov; 119(10):1164-72. PubMed ID: 25930027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonclassical Monocytes Sense Hypoxia, Regulate Pulmonary Vascular Remodeling, and Promote Pulmonary Hypertension.
    Yu YA; Malakhau Y; Yu CA; Phelan SJ; Cumming RI; Kan MJ; Mao L; Rajagopal S; Piantadosi CA; Gunn MD
    J Immunol; 2020 Mar; 204(6):1474-1485. PubMed ID: 31996456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia-Inducible Factor 1α Is a Critical Downstream Mediator for Hypoxia-Induced Mitogenic Factor (FIZZ1/RELMα)-Induced Pulmonary Hypertension.
    Johns RA; Takimoto E; Meuchel LW; Elsaigh E; Zhang A; Heller NM; Semenza GL; Yamaji-Kegan K
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):134-44. PubMed ID: 26586659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adventitial fibroblasts induce a distinct proinflammatory/profibrotic macrophage phenotype in pulmonary hypertension.
    El Kasmi KC; Pugliese SC; Riddle SR; Poth JM; Anderson AL; Frid MG; Li M; Pullamsetti SS; Savai R; Nagel MA; Fini MA; Graham BB; Tuder RM; Friedman JE; Eltzschig HK; Sokol RJ; Stenmark KR
    J Immunol; 2014 Jul; 193(2):597-609. PubMed ID: 24928992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of interleukin-6 on hypoxia-induced pulmonary hypertension and lung inflammation in mice.
    Savale L; Tu L; Rideau D; Izziki M; Maitre B; Adnot S; Eddahibi S
    Respir Res; 2009 Jan; 10(1):6. PubMed ID: 19173740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms.
    Stenmark KR; Fagan KA; Frid MG
    Circ Res; 2006 Sep; 99(7):675-91. PubMed ID: 17008597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension.
    Lee C; Mitsialis SA; Aslam M; Vitali SH; Vergadi E; Konstantinou G; Sdrimas K; Fernandez-Gonzalez A; Kourembanas S
    Circulation; 2012 Nov; 126(22):2601-11. PubMed ID: 23114789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage-derived inflammation promotes pulmonary vascular remodeling in hypoxia-induced pulmonary arterial hypertension mice.
    Liu H; Wang Y; Zhang Q; Liu C; Ma Y; Huang P; Ge R; Ma L
    Immunol Lett; 2023 Nov; 263():113-122. PubMed ID: 37875238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early macrophage recruitment and alternative activation are critical for the later development of hypoxia-induced pulmonary hypertension.
    Vergadi E; Chang MS; Lee C; Liang OD; Liu X; Fernandez-Gonzalez A; Mitsialis SA; Kourembanas S
    Circulation; 2011 May; 123(18):1986-95. PubMed ID: 21518986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The six-transmembrane protein Stamp2 ameliorates pulmonary vascular remodeling and pulmonary hypertension in mice.
    Batool M; Berghausen EM; Zierden M; Vantler M; Schermuly RT; Baldus S; Rosenkranz S; Ten Freyhaus H
    Basic Res Cardiol; 2020 Nov; 115(6):68. PubMed ID: 33188479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose fluvastatin reverses the hypoxic pulmonary adventitial fibroblast phenotype in experimental pulmonary hypertension.
    Carlin CM; Celnik DF; Pak O; Wadsworth R; Peacock AJ; Welsh DJ
    Am J Respir Cell Mol Biol; 2012 Aug; 47(2):140-8. PubMed ID: 22383583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemoglobin-induced lung vascular oxidation, inflammation, and remodeling contribute to the progression of hypoxic pulmonary hypertension and is attenuated in rats with repeated-dose haptoglobin administration.
    Irwin DC; Baek JH; Hassell K; Nuss R; Eigenberger P; Lisk C; Loomis Z; Maltzahn J; Stenmark KR; Nozik-Grayck E; Buehler PW
    Free Radic Biol Med; 2015 May; 82():50-62. PubMed ID: 25656991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IGF-1 signaling in neonatal hypoxia-induced pulmonary hypertension: Role of epigenetic regulation.
    Yang Q; Sun M; Ramchandran R; Raj JU
    Vascul Pharmacol; 2015 Oct; 73():20-31. PubMed ID: 25921925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central role of T helper 17 cells in chronic hypoxia-induced pulmonary hypertension.
    Maston LD; Jones DT; Giermakowska W; Howard TA; Cannon JL; Wang W; Wei Y; Xuan W; Resta TC; Gonzalez Bosc LV
    Am J Physiol Lung Cell Mol Physiol; 2017 May; 312(5):L609-L624. PubMed ID: 28213473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RELMα Licenses Macrophages for Damage-Associated Molecular Pattern Activation to Instigate Pulmonary Vascular Remodeling.
    Lin Q; Fan C; Skinner JT; Hunter EN; Macdonald AA; Illei PB; Yamaji-Kegan K; Johns RA
    J Immunol; 2019 Dec; 203(11):2862-2871. PubMed ID: 31611261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ythdf2 promotes pulmonary hypertension by suppressing Hmox1-dependent anti-inflammatory and antioxidant function in alveolar macrophages.
    Hu L; Yu Y; Shen Y; Huang H; Lin D; Wang K; Yu Y; Li K; Cao Y; Wang Q; Sun X; Qiu Z; Wei D; Shen B; Chen J; Fulton D; Ji Y; Wang J; Chen F
    Redox Biol; 2023 May; 61():102638. PubMed ID: 36801705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.